FDA Inspection 1026018 — Department of Defense - Air Force

Department of Defense - Air Force — FEI 1577551

The FDA completed an inspection of Department of Defense - Air Force on September 19, 2017 in Dayton, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 19, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dayton, OH (United States)